Contributions of the author Steven R. Patierno are not fully acknowledged in this Article. The Author Contributions section should have included the following:
‘S.R.P. was involved in the co-conception of the study, and was co-principal investigator of the initial portion of this study by obtaining NCI Center to Reduce Cancer Health Disparities grant supplement U01CA11637-05S2 (to S.R.P.) that supported initial experiments towards differential alternative splicing events, oncogenic splicing pathway, validation of differential alternative splicing and selective knockdown of PIK3CD L and S variants.’
Additional information
The online version of the original article can be found at 10.1038/ncomms15921
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wang, BD., Ceniccola, K., Hwang, S. et al. Correction: Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun 8, 16161 (2017). https://doi.org/10.1038/ncomms16161
Published:
DOI: https://doi.org/10.1038/ncomms16161
